Smelling Illness: Volatile Organic Compounds as Neurological Disease Biomarkers

Scientists advance Parkinson’s disease biomarker research one sniff at a time.

Written byThe Scientist
| 1 min read
iStock
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Early diagnosis and treatment of Parkinson’s disease is critical to slowing its progression. Long before neurological symptoms appear, patients exhibit early signs, some of which are associated with specific chemical scent signatures known as volatile organic compounds. Researchers study these as early biomarkers of disease for future diagnostics applications.

In this episode, Iris Kulbatski from The Scientist spoke with Drupad Trivedi, a University of Manchester biomedical researcher and lecturer in analytical and measurement science, to learn more about how fatty skin secretions in Parkinson’s disease and one woman’s sensitive nose may lead to early detection and intervention.

More on this topic

Disease Scent Signatures Disclose What the Nose Knows

Dogs Engage in Scent-sational Science to Sniff out Staphylococcus Bacteria

The Scientist Speaks is a podcast produced by The Scientist’s Creative Services Team. Our podcast is by scientists and for scientists. Once a month, we bring you the stories behind news-worthy molecular biology research.


Speaker:

<strong >Drupad Trivedi, PhD</strong>

Drupad Trivedi, PhD
CAMS Lecturer
Analytical and Measurement Sciences
Department of Chemistry, School of Natural Sciences
Faculty of Science and Engineering
The University of Manchester


Transcript

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio&nbsp;
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA